Prof. Nathan Fowler | ICML 2017 | Long-term follow-up of lenalidomide + rituximab in iNHL

Anne Villeneuve

Nathan Fowler

Jun 22, 2017

Long-term follow-up of lenalidomide + rituximab in iNHL

More about...

Anne Villeneuve ICML 2017 Indolent B-cell lymphomas Lenalidomide Nathan Fowler Rituximab

Lymphoma Hub Satellite Symposium 2019 | Chemo-free approaches for the treatment of lymphoid malignancies - Professor Nathan Fowler

Professor Nathan Fowler, University of Texas MD Anderson Cancer Centre, Houston, US, presented the current state of...

Jul 29, 2019

Lymphoma Hub Satellite Symposium 2019 | Chemo-free approaches for the treatment of lymphoid malignancies - Professor Nathan Fowler

Professor Nathan Fowler, University of Texas MD Anderson Cancer...

Jul 29, 2019

ICML 2017 | Chemotherapy-free combinations for patients with B-cell NHL – Focus On Session

One of the “Focus On” Sessions at 14-ICML in Lugano, Switzerland, was based around chemotherapy-free combinations in patients with B-cell NHL, including those...

Jun 19, 2017

ICML 2017 | Chemotherapy-free combinations for patients with B-cell NHL – Focus On Session

One of the “Focus On” Sessions at 14-ICML in Lugano, Switzerland, was based around chemotherapy-free...

Jun 19, 2017

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

I agree to the Lymphoma Hub Terms & Conditions

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. Nathan Fowler | ICML 2017 | Long-term follow-up of lenalidomide + rituximab in iNHL

Anne Villeneuve

Nathan Fowler

Jun 22, 2017

More about...

Related articles

Jul 29, 2019

Jul 29, 2019

Jun 19, 2017

Jun 19, 2017

Newsletter